The Innovation Agency created a North West Coast Atrial Fibrillation (AF) Collaborative to enable GPs to better identify patients with AF and improve management of the condition. To date, the Collaborative has involved 71 GP practices in the CCG areas of Warrington, East Lancashire, Blackburn with Darwen, West Cheshire and Wirral. The Collaborative has facilitated the delivery of AF educational sessions and materials, the distribution of Kardia Mobile ECG devices and Quality Improvement (QI) training and support in developing and implementing practice improvement plans.
This document is a framework service specification for the delivery of anticoagulation services for people with atrial fibrillation (AF).
The specification was developed by Anticoagulation UK in close collaboration with experts in anticoagulation from across primary, community and secondary care. The standards within this framework reflect best practice for services to adhere to, both during and beyond the COVID-19 pandemic.
This project has been fully funded by Bayer plc. The content is independent of and not influenced by Bayer plc who checked the final document for technical accuracy only.